Piperazine designer drugs of abuse

被引：29

作者：

Staack, Roland F. ^{[1
]}

机构：

[1] Univ Munich, Inst Forens Med, Dept Forens Toxicol, D-80337 Munich, Germany

来源：

LANCET | 2007年 / 369卷 / 9571期

关键词：

D O I：

10.1016/S0140-6736(07)60646-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1411 / 1413

页数：3

共 11 条

[1] Fatal brain oedema after ingestion of ecstasy and benzylpiperazine
Balmelli, C
Kupferschmidt, H
Rentsch, K
Schneemann, M
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (28-29) : 809 - 811
[2] N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')
Baumann, MH
Clark, RD
Budzynski, AG
Partilla, JS
Blough, BE
Rothman, RB
[J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 (03) : 550 - 560
[3] Drug Enforcement Administration (DEA) Department of Justice, 2004, Fed Regist, V69, P12794
[4] *EUR MON CTR DRUGS, 2007, EUR EMCDDA JOINT REP
[5] Gee Paul, 2005, N Z Med J, V118, pU1784
[6] Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine
Klaassen, T
Pian, KLH
Westenberg, HGM
den Boer, JA
van Praag, HM
[J]. PSYCHIATRY RESEARCH, 1998, 79 (03) : 207 - 212
[7] Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control
Maurer, HH
[J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (11) : 1310 - 1324
[8] Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry
Peters, FT
Schaefer, S
Staack, RF
Kraemer, T
Maurer, HH
[J]. JOURNAL OF MASS SPECTROMETRY, 2003, 38 (06): : 659 - 676
[9] Metabolism of designer drugs of abuse
Staack, RF
Maurer, HH
[J]. CURRENT DRUG METABOLISM, 2005, 6 (03) : 259 - 274
[10] A2 (N-benzylpiperazine) a new drug of abuse in Sweden
Wikström, M
Holmgren, P
Ahlner, J
[J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (01) : 67 - 70

← 1 2 →